Baltimore, MD, United States of America

Grace Kuroki

This inventor holds 1 USPTO granted patent. Top assignee: Johns Hopkins University. Active years: 2025.


% Patents Active = 100.0

Average Co-Inventor Count = 10.0

ph-index = 1


Company Filing History:


Years Active: 2025

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Grace Kuroki: Innovator in Cryosurgical Technology

Introduction

Grace Kuroki is a notable inventor based in Baltimore, MD (US). She has made significant contributions to the field of medical technology, particularly in cryosurgery. Her innovative approach has the potential to enhance treatment options for patients with tumorous masses.

Latest Patents

Grace Kuroki holds a patent for a Carbon dioxide-based percutaneous cryosurgical system. This invention provides a handheld cryoprobe designed for use in percutaneous cryotherapy of tumorous masses. The system includes a probe attached to a CO2 gas dispensing backend, optimized for effective heat exchange. The backend regulates the flow of compressed CO2 while cooling the gas to cytotoxically low temperatures necessary for targeted tumor cell death. The design incorporates a Joule-Thomson nozzle that enhances the cooling process, creating a positive feedback loop that continually decreases the gas's temperature at the probe tip.

Career Highlights

Grace Kuroki is affiliated with Johns Hopkins University, where she contributes to cutting-edge research and development in medical technologies. Her work is characterized by a commitment to improving patient outcomes through innovative solutions.

Collaborations

Grace collaborates with talented individuals such as Bailey Surtees and Evelyn McChesney, who share her passion for advancing medical technology.

Conclusion

Grace Kuroki's contributions to cryosurgical technology exemplify the impact of innovation in medicine. Her work not only showcases her inventive spirit but also holds promise for improving treatment methodologies for patients.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…